◼ Archived
Health
🔮 fades ✗
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The FDA approval of a landmark pancreatic cancer drug costing $480,000 annually signals a shifting economic landscape for oncology treatments.